Skip to main content

'Microrobot' Pills Eased IBD in Mice, Paving Way for Human Testing

Medically reviewed by Carmen Pope, BPharm. Last updated on June 28, 2024.

By Dennis Thompson HealthDay Reporter

FRIDAY, June 28, 2024 -- A new "microrobot" pill may help tame inflammatory bowel disease (IBD), a new study in mice suggests.

The pill significantly reduced IBD symptoms in mice and promoted the healing of damaged colon tissue without toxic side effects, researchers reported June 26 in the journal Science Robotics.

IBD occurs when immune cells turn on the gut, creating excessive levels of inflammation-causing chemicals called cytokines, researchers said. The microbots are designed to keep those cytokine levels in check, researchers explained.

The microbots consist of inflammation-fighting nanoparticles attached to the surface of green algae cells, researchers explained.

The algae enables the nanoparticles to swim around inside the gut. The nanoparticles absorb and neutralize cytokines as they come across them.

This breaks the cycle of inflammation that triggers IBD, giving damaged gut tissue a chance to heal, researchers said.

“The beauty of this approach is that it’s drug-free -- we just leverage the natural cell membrane to absorb and neutralize pro-inflammatory cytokines,” said lead researcher Liangfang Zhang, a professor of chemical and nano engineering at the University of California, San Diego (UCSD).

The microrobots are packed inside a liquid capsule that’s resistant to stomach acid but melts upon reaching the neutral pH of the colon, researchers explained. This makes sure they get where they’re needed.

“We can direct the microrobots to the diseased location without affecting other organs,” said lead researcher Joseph Wang, a professor of chemical and nano engineering at the UCSD. “In this way, we can minimize toxicity.”

When fed to mice, the microrobot capsules reduced fecal bleeding, improved stool consistency, reversed weight loss associated with IBD and reduced inflammation in the colon, researchers said.

However, it should be noted that the research is early and much animal research does not pan out in humans.

Earlier this month, a report in the journal Science Advances from the same team showed that microrobot technology can be used to deliver chemotherapy directly to lung cancer cells.

“This is a platform technology that can actively and efficiently deliver therapeutics throughout the entire lung tissue to combat different types of deadly diseases in the lungs,” Zhang said of that application.

Sources

  • University of California, San Diego, news release, June 26, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted June 2024

Read this next

FDA Approves Tremfya for Active Crohn Disease in Adults

MONDAY, March 24, 2025 -- The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for adult patients with moderately to severely active Crohn disease. This...

Can't Find a Gastroenterologist? You're Not Alone

MONDAY, Feb. 17, 2025 -- Nearly 50 million Americans live in counties with no local gastroenterologist. Gastroenterologists diagnose and treat disorders affecting the GI tract --...

FDA Approves Omvoh for Moderately to Severely Active Crohn Disease

THURSDAY, Jan. 16, 2025 -- The U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn disease in adults...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.